1718 - In Vitro Activity of Imipenem/Relebactam against Class C β-lactamase-Positive Enterobacterales in the Asia/Pacific Region: SMART 2018-2020

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

Mark Estabrook, PhD

Laboratory Manager, Molecular Microbiology
IHMA
Schaumburg, Illinois, United States

WC

Wei-Ting Chen, MD

Regional Director of Medical Affairs
MSD Taiwan
Taipei, Taipei, Taiwan
FS

Fakhar Siddiqui, MD, MBA

Merck & Co., Inc.
Rahway, New Jersey, United States
Katherine Young, M.S. (she/her/hers)

Senior Principal Scientist
Merck
Rahway, New Jersey, United States
MM

Mary Motyl, Ph.D.

Distinguished Senior Principal Scientist
Merck
Rahway, New Jersey, United States
DS

Daniel F. Sahm, PhD

VP Global Microbiology Services & Chief Scientific Officer
IHMA
Schaumburg, Illinois, United States